Results 221 to 230 of about 2,745,887 (383)

Allergic Sensitization to Inhalant Allergens in the Upper Respiratory Tract—the B Cell Side

Allergy, EarlyView.
ABSTRACT Allergic diseases are on the rise worldwide, driven by respiratory epithelial barrier dysfunction that promotes sensitization to inhalant allergens such as pollen, dust mites, pet dander, and fungal spores. These antigens trigger IgE‐mediated immune responses that lead to diseases such as allergic rhinitis (AR) and asthma.
Ola Grimsholm, Mohammed Zghaebi, Bita Hambrecht, Tanja Kalic, Christopher C. Udoye, Rudolf Manz, Barbara Bohle, Katarzyna M. Sitnik, Julia Eckl‐Dorna, Heimo Breiteneder   +9 more
wiley   +1 more source

Chronic Rhinosinusitis With Nasal Polyps and Asthma.

Journal of Allergy and Clinical Immunology: In Practice, 2020
T. Laidlaw, J. Mullol, K. Woessner, N. Amin, L. Mannent   +4 more
semanticscholar   +1 more source

Early and Sustained Asthma Control and Remission in Real‐World Patients With Severe Eosinophilic Asthma Treated With Benralizumab: XALOC‐2

Clinical &Experimental Allergy, EarlyView.
Real‐world patients with severe eosinophilic asthma treated with benralizumab showed early and sustained improvements in symptoms. Clinically meaningful improvements began as early as one week after benralizumab initiation, regardless of previous biologic use, and further improved over the following year.
Erika Penz, Thomas Rothe, Lieven Dupont, Trung N. Tran, Andrew Menzies‐Gow, Anat Shavit, David Cohen, Tanja Plate, Sheena Kayaniyil, An Herreman, Claudio Schuoler, Benjamin Emmanuel, Marek Lommatzsch   +12 more
wiley   +1 more source

Polymicrobial biofilms in chronic rhinosinusitis: a scoping review. [PDF]

J Med Microbiol
Broderick D, Biswas K, Kim R, Douglas R.
europepmc   +1 more source

Dupilumab Dampens Mucosal Type 2 Response During Acetylsalicylic Acid Challenge in N‐ERD Patients

Clinical &Experimental Allergy, EarlyView.
Dupilumab therapy reduced elevated type 2 cytokine responses post‐ASA provocation in N‐ERD patients, independent of ASA tolerance, and revealed novel mechanistic insights by modulating acute type 2 immunity. Transcriptomic analysis showed concurrent downregulation of lipid and peroxisome pathways during ASA challenge in N‐ERD patients after 24 weeks of
Julia Eckl‐Dorna, Christina Morgenstern, Katharina Poglitsch, Tamara Arnoldner, Katharina Gangl, Tina J. Bartosik, Nicholas J. Campion, Aldine Tu, Victoria Stanek, Sven Schneider, Christine Bangert   +10 more
wiley   +1 more source

The exploration of immunological landscape and drug targets in chronic rhinosinusitis with nasal polyps. [PDF]

World Allergy Organ J
Zhang R, Fu P, Tian H.
europepmc   +1 more source

The Need to Promote Olfactory Health in Public Health Agendas Across the Globe

Clinical Otolaryngology, EarlyView.
ABSTRACT Background A good sense of smell is essential for physical and mental health, and social wellbeing; however, across the globe, regardless of the setting, national public health agendas never consider smell health. This review aims to summarise the wide‐reaching impact of smell health in public health. Methods Narrative review of the literature
Carl Martin Philpott, Thomas Hummel, Valentina Parma, Matt Lechner, Duncan Boak, Marianna Obrist   +5 more
wiley   +1 more source

Relationship between staphylococcal enterotoxin superantigens and the development of chronic rhinosinusitis. [PDF]

Medicine (Baltimore)
Zhu B, Chen F, Cao Q.
europepmc   +1 more source

Therapeutic ultrasound for chronic rhinosinusitis [PDF]

, 2014
Ahmed, Ansari, Baker, Bartley, Batavia, Benninger, Chan, Cherry, Chin, Fairley, Fokkens, Harvey, Hǿsǿien, Khalil, Kim, Kormos, Leung, Naghdi, Piccirillo, Piromchai, Ragab, Rocha, Schortinghuis, Shashy, Tan, Timperley, Young   +26 more
core   +1 more source

Expression of HORMAD1 in Chronic Rhinosinusitis and Its Correlation with Inflammatory Factors

Xin Zhang, Yu Xu, Jinhui Zhou
openalex   +2 more sources